Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    70604
Show Display Options
Rank Status Study
1 Active, not recruiting Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
Conditions: Breast Adenocarcinoma;   DS Stage I Plasma Cell Myeloma;   DS Stage II Plasma Cell Myeloma;   Metastatic Malignant Neoplasm to the Bone;   Pain;   Musculoskeletal Complication;   Urinary Complications
Intervention: Drug: zoledronic acid
2 Active, not recruiting Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Conditions: Prostate Cancer;   Breast Cancer;   Lung Cancer;   Colorectal Cancer;   Leukemia;   Multiple Myeloma
Interventions: Other: internet-based intervention;   Other: assessment of therapy complications;   Other: Questionnaire Administration

Study has passed its completion date and status has not been verified in more than two years.